NCT03576131 · OUTCOME
Time to Reach Maximum Observed Concentration (Tmax) of Hx-DR5-01 and Hx-DR5-05
GEN1029 (HexaBody®-DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors · Source last updated 2023-08-01
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- MEDIAN
- Unit
- h
- Interval / dispersion
- Full Range
- Time frame
- Predose, end of infusion, 2, 4, 24, 48, 168 and 336 hours after end of infusion on Day 1 of Cycles 1, 2, 3
What was measured
The Tmax of Hx-DR5-01 and Hx-DR5-05 are reported.
Analysis population: PK analysis set included all participants who were exposed to at least 1 dose of GEN1029 and who had at least 1 post-dose PK measurement. 'Number analyzed' denotes the number of participants evaluated for the specified time point.
Groups in this outcome
1. Biweekly Regimen (GEN1029 0.1 mg/kg)
Participants received 0.1 mg/kg of GEN1029 every 2 weeks (Q2W) until the end of treatment.
2. Biweekly Regimen (GEN1029 0.2 mg/kg)
Participants received 0.2 mg/kg of GEN1029 Q2W until the end of treatment.
3. Biweekly Regimen (GEN1029 0.3 mg/kg)
Participants received 0.3 mg/kg of GEN1029 Q2W until the end of treatment.
4. Biweekly Regimen (GEN1029 1.0 mg/kg)
Participants received 1.0 mg/kg of GEN1029 Q2W until the end of treatment.
5. Biweekly Regimen (GEN1029 2.0 mg/kg)
Participants received 2.0 mg/kg of GEN1029 Q2W until the end of treatment.
6. Biweekly Regimen (GEN1029 3.0 mg/kg)
Participants received 3.0 mg/kg of GEN1029 Q2W until the end of treatment.
Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.
Analysis denominator · Participants
| Group | Source count |
|---|
| 1. Biweekly Regimen (GEN1029 0.1 mg/kg) | 9 |
|---|
| 2. Biweekly Regimen (GEN1029 0.2 mg/kg) | 7 |
|---|
| 3. Biweekly Regimen (GEN1029 0.3 mg/kg) | 4 |
|---|
| 4. Biweekly Regimen (GEN1029 1.0 mg/kg) | 11 |
|---|
| 5. Biweekly Regimen (GEN1029 2.0 mg/kg) | 7 |
|---|
| 6. Biweekly Regimen (GEN1029 3.0 mg/kg) | 6 |
|---|
Reported measurements
Tmax Hx-DR5-01 Cycle 1 Day 1
Analysis denominator · Participants
| Group | Source count |
|---|
| 1. Biweekly Regimen (GEN1029 0.1 mg/kg) | 9 |
|---|
| 2. Biweekly Regimen (GEN1029 0.2 mg/kg) | 6 |
|---|
| 3. Biweekly Regimen (GEN1029 0.3 mg/kg) | 4 |
|---|
| 4. Biweekly Regimen (GEN1029 1.0 mg/kg) | 11 |
|---|
| 5. Biweekly Regimen (GEN1029 2.0 mg/kg) | 7 |
|---|
| 6. Biweekly Regimen (GEN1029 3.0 mg/kg) | 6 |
|---|
Values in h · Interval/dispersion: Full Range| Group | Value | Spread | Lower | Upper | Comment |
|---|
| 1. Biweekly Regimen (GEN1029 0.1 mg/kg) | 1.58 | Not reported | 1.1 | 5.8 | Not reported |
|---|
| 2. Biweekly Regimen (GEN1029 0.2 mg/kg) | 1.89 | Not reported | 1.4 | 5.0 | Not reported |
|---|
| 3. Biweekly Regimen (GEN1029 0.3 mg/kg) | 1.23 | Not reported | 1.2 | 1.4 | Not reported |
|---|
| 4. Biweekly Regimen (GEN1029 1.0 mg/kg) | 2.00 | Not reported | 0.1 | 4.7 | Not reported |
|---|
| 5. Biweekly Regimen (GEN1029 2.0 mg/kg) | 1.30 | Not reported | 1.1 | 3.6 | Not reported |
|---|
| 6. Biweekly Regimen (GEN1029 3.0 mg/kg) | 1.46 | Not reported | 1.0 | 3.1 | Not reported |
|---|
Tmax Hx-DR5-01 Cycle 2 Day 1
Analysis denominator · Participants
| Group | Source count |
|---|
| 1. Biweekly Regimen (GEN1029 0.1 mg/kg) | 9 |
|---|
| 2. Biweekly Regimen (GEN1029 0.2 mg/kg) | 4 |
|---|
| 3. Biweekly Regimen (GEN1029 0.3 mg/kg) | 4 |
|---|
| 4. Biweekly Regimen (GEN1029 1.0 mg/kg) | 8 |
|---|
| 5. Biweekly Regimen (GEN1029 2.0 mg/kg) | 5 |
|---|
| 6. Biweekly Regimen (GEN1029 3.0 mg/kg) | 2 |
|---|
Values in h · Interval/dispersion: Full Range| Group | Value | Spread | Lower | Upper | Comment |
|---|
| 1. Biweekly Regimen (GEN1029 0.1 mg/kg) | 1.25 | Not reported | 1.0 | 3.2 | Not reported |
|---|
| 2. Biweekly Regimen (GEN1029 0.2 mg/kg) | 3.03 | Not reported | 3.0 | 5.2 | Not reported |
|---|
| 3. Biweekly Regimen (GEN1029 0.3 mg/kg) | 1.30 | Not reported | 1.1 | 3.2 | Not reported |
|---|
| 4. Biweekly Regimen (GEN1029 1.0 mg/kg) | 3.06 | Not reported | 1.1 | 5.1 | Not reported |
|---|
| 5. Biweekly Regimen (GEN1029 2.0 mg/kg) | 3.25 | Not reported | 1.1 | 163.7 | Not reported |
|---|
| 6. Biweekly Regimen (GEN1029 3.0 mg/kg) | 1.11 | Not reported | 1.0 | 1.2 | Not reported |
|---|
Tmax Hx-DR5-01 Cycle 3 Day 1
Analysis denominator · Participants
| Group | Source count |
|---|
| 1. Biweekly Regimen (GEN1029 0.1 mg/kg) | 7 |
|---|
| 2. Biweekly Regimen (GEN1029 0.2 mg/kg) | 4 |
|---|
| 3. Biweekly Regimen (GEN1029 0.3 mg/kg) | 3 |
|---|
| 4. Biweekly Regimen (GEN1029 1.0 mg/kg) | 6 |
|---|
| 5. Biweekly Regimen (GEN1029 2.0 mg/kg) | 3 |
|---|
| 6. Biweekly Regimen (GEN1029 3.0 mg/kg) | 1 |
|---|
Values in h · Interval/dispersion: Full Range| Group | Value | Spread | Lower | Upper | Comment |
|---|
| 1. Biweekly Regimen (GEN1029 0.1 mg/kg) | 1.08 | Not reported | 0.0 | 3.4 | Not reported |
|---|
| 2. Biweekly Regimen (GEN1029 0.2 mg/kg) | 1.48 | Not reported | 1.0 | 2.1 | Not reported |
|---|
| 3. Biweekly Regimen (GEN1029 0.3 mg/kg) | 1.13 | Not reported | 1.1 | 1.3 | Not reported |
|---|
| 4. Biweekly Regimen (GEN1029 1.0 mg/kg) | 3.08 | Not reported | 1.4 | 3.5 | Not reported |
|---|
| 5. Biweekly Regimen (GEN1029 2.0 mg/kg) | 1.82 | Not reported | 1.1 | 3.2 | Not reported |
|---|
| 6. Biweekly Regimen (GEN1029 3.0 mg/kg) | 3.1 | Not reported | 3.1 | 3.1 | Not reported |
|---|
Tmax Hx-DR5-05 Cycle 1 Day 1
Analysis denominator · Participants
| Group | Source count |
|---|
| 1. Biweekly Regimen (GEN1029 0.1 mg/kg) | 9 |
|---|
| 2. Biweekly Regimen (GEN1029 0.2 mg/kg) | 6 |
|---|
| 3. Biweekly Regimen (GEN1029 0.3 mg/kg) | 4 |
|---|
| 4. Biweekly Regimen (GEN1029 1.0 mg/kg) | 11 |
|---|
| 5. Biweekly Regimen (GEN1029 2.0 mg/kg) | 7 |
|---|
| 6. Biweekly Regimen (GEN1029 3.0 mg/kg) | 6 |
|---|
Values in h · Interval/dispersion: Full Range| Group | Value | Spread | Lower | Upper | Comment |
|---|
| 1. Biweekly Regimen (GEN1029 0.1 mg/kg) | 1.75 | Not reported | 1.1 | 5.4 | Not reported |
|---|
| 2. Biweekly Regimen (GEN1029 0.2 mg/kg) | 2.53 | Not reported | 1.0 | 4.8 | Not reported |
|---|
| 3. Biweekly Regimen (GEN1029 0.3 mg/kg) | 2.36 | Not reported | 1.2 | 5.5 | Not reported |
|---|
| 4. Biweekly Regimen (GEN1029 1.0 mg/kg) | 1.60 | Not reported | 0.1 | 4.7 | Not reported |
|---|
| 5. Biweekly Regimen (GEN1029 2.0 mg/kg) | 1.35 | Not reported | 1.1 | 3.0 | Not reported |
|---|
| 6. Biweekly Regimen (GEN1029 3.0 mg/kg) | 1.46 | Not reported | 1.0 | 3.1 | Not reported |
|---|
Tmax Hx-DR5-05 Cycle 2 Day 1
Analysis denominator · Participants
| Group | Source count |
|---|
| 1. Biweekly Regimen (GEN1029 0.1 mg/kg) | 9 |
|---|
| 2. Biweekly Regimen (GEN1029 0.2 mg/kg) | 4 |
|---|
| 3. Biweekly Regimen (GEN1029 0.3 mg/kg) | 4 |
|---|
| 4. Biweekly Regimen (GEN1029 1.0 mg/kg) | 8 |
|---|
| 5. Biweekly Regimen (GEN1029 2.0 mg/kg) | 4 |
|---|
| 6. Biweekly Regimen (GEN1029 3.0 mg/kg) | 2 |
|---|
Values in h · Interval/dispersion: Full Range| Group | Value | Spread | Lower | Upper | Comment |
|---|
| 1. Biweekly Regimen (GEN1029 0.1 mg/kg) | 3.12 | Not reported | 1.1 | 5.1 | Not reported |
|---|
| 2. Biweekly Regimen (GEN1029 0.2 mg/kg) | 2.19 | Not reported | 1.0 | 3.5 | Not reported |
|---|
| 3. Biweekly Regimen (GEN1029 0.3 mg/kg) | 1.19 | Not reported | 1.0 | 1.4 | Not reported |
|---|
| 4. Biweekly Regimen (GEN1029 1.0 mg/kg) | 2.26 | Not reported | 1.2 | 5.1 | Not reported |
|---|
| 5. Biweekly Regimen (GEN1029 2.0 mg/kg) | 2.31 | Not reported | 1.1 | 3.3 | Not reported |
|---|
| 6. Biweekly Regimen (GEN1029 3.0 mg/kg) | 2.21 | Not reported | 1.2 | 3.2 | Not reported |
|---|
Tmax Hx-DR5-05 Cycle 3 Day 1
Analysis denominator · Participants
| Group | Source count |
|---|
| 1. Biweekly Regimen (GEN1029 0.1 mg/kg) | 7 |
|---|
| 2. Biweekly Regimen (GEN1029 0.2 mg/kg) | 4 |
|---|
| 3. Biweekly Regimen (GEN1029 0.3 mg/kg) | 2 |
|---|
| 4. Biweekly Regimen (GEN1029 1.0 mg/kg) | 6 |
|---|
| 5. Biweekly Regimen (GEN1029 2.0 mg/kg) | 3 |
|---|
| 6. Biweekly Regimen (GEN1029 3.0 mg/kg) | 1 |
|---|
Values in h · Interval/dispersion: Full Range| Group | Value | Spread | Lower | Upper | Comment |
|---|
| 1. Biweekly Regimen (GEN1029 0.1 mg/kg) | 1.08 | Not reported | 0.0 | 1.5 | Not reported |
|---|
| 2. Biweekly Regimen (GEN1029 0.2 mg/kg) | 1.83 | Not reported | 1.0 | 3.3 | Not reported |
|---|
| 3. Biweekly Regimen (GEN1029 0.3 mg/kg) | 1.18 | Not reported | 1.1 | 1.3 | Not reported |
|---|
| 4. Biweekly Regimen (GEN1029 1.0 mg/kg) | 1.42 | Not reported | 1.1 | 3.0 | Not reported |
|---|
| 5. Biweekly Regimen (GEN1029 2.0 mg/kg) | 1.13 | Not reported | 1.0 | 1.8 | Not reported |
|---|
| 6. Biweekly Regimen (GEN1029 3.0 mg/kg) | 3.1 | Not reported | 3.1 | 3.1 | Not reported |
|---|
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- lower Limit
- 1.1
- upper Limit
- 5.8
- value
- 1.58
- group Id
- OG001
- lower Limit
- 1.4
- upper Limit
- 5.0
- value
- 1.89
- group Id
- OG002
- lower Limit
- 1.2
- upper Limit
- 1.4
- value
- 1.23
- group Id
- OG003
- lower Limit
- 0.1
- upper Limit
- 4.7
- value
- 2.00
- group Id
- OG004
- lower Limit
- 1.1
- upper Limit
- 3.6
- value
- 1.30
- group Id
- OG005
- lower Limit
- 1.0
- upper Limit
- 3.1
- value
- 1.46
- denoms
- counts
- group Id
- OG000
- value
- 9
- group Id
- OG001
- value
- 6
- group Id
- OG002
- value
- 4
- group Id
- OG003
- value
- 11
- group Id
- OG004
- value
- 7
- group Id
- OG005
- value
- 6
- units
- Participants
- title
- Tmax Hx-DR5-01 Cycle 1 Day 1
- categories
- measurements
- group Id
- OG000
- lower Limit
- 1.0
- upper Limit
- 3.2
- value
- 1.25
- group Id
- OG001
- lower Limit
- 3.0
- upper Limit
- 5.2
- value
- 3.03
- group Id
- OG002
- lower Limit
- 1.1
- upper Limit
- 3.2
- value
- 1.30
- group Id
- OG003
- lower Limit
- 1.1
- upper Limit
- 5.1
- value
- 3.06
- group Id
- OG004
- lower Limit
- 1.1
- upper Limit
- 163.7
- value
- 3.25
- group Id
- OG005
- lower Limit
- 1.0
- upper Limit
- 1.2
- value
- 1.11
- denoms
- counts
- group Id
- OG000
- value
- 9
- group Id
- OG001
- value
- 4
- group Id
- OG002
- value
- 4
- group Id
- OG003
- value
- 8
- group Id
- OG004
- value
- 5
- group Id
- OG005
- value
- 2
- units
- Participants
- title
- Tmax Hx-DR5-01 Cycle 2 Day 1
- categories
- measurements
- group Id
- OG000
- lower Limit
- 0.0
- upper Limit
- 3.4
- value
- 1.08
- group Id
- OG001
- lower Limit
- 1.0
- upper Limit
- 2.1
- value
- 1.48
- group Id
- OG002
- lower Limit
- 1.1
- upper Limit
- 1.3
- value
- 1.13
- group Id
- OG003
- lower Limit
- 1.4
- upper Limit
- 3.5
- value
- 3.08
- group Id
- OG004
- lower Limit
- 1.1
- upper Limit
- 3.2
- value
- 1.82
- group Id
- OG005
- lower Limit
- 3.1
- upper Limit
- 3.1
- value
- 3.1
- denoms
- counts
- group Id
- OG000
- value
- 7
- group Id
- OG001
- value
- 4
- group Id
- OG002
- value
- 3
- group Id
- OG003
- value
- 6
- group Id
- OG004
- value
- 3
- group Id
- OG005
- value
- 1
- units
- Participants
- title
- Tmax Hx-DR5-01 Cycle 3 Day 1
- categories
- measurements
- group Id
- OG000
- lower Limit
- 1.1
- upper Limit
- 5.4
- value
- 1.75
- group Id
- OG001
- lower Limit
- 1.0
- upper Limit
- 4.8
- value
- 2.53
- group Id
- OG002
- lower Limit
- 1.2
- upper Limit
- 5.5
- value
- 2.36
- group Id
- OG003
- lower Limit
- 0.1
- upper Limit
- 4.7
- value
- 1.60
- group Id
- OG004
- lower Limit
- 1.1
- upper Limit
- 3.0
- value
- 1.35
- group Id
- OG005
- lower Limit
- 1.0
- upper Limit
- 3.1
- value
- 1.46
- denoms
- counts
- group Id
- OG000
- value
- 9
- group Id
- OG001
- value
- 6
- group Id
- OG002
- value
- 4
- group Id
- OG003
- value
- 11
- group Id
- OG004
- value
- 7
- group Id
- OG005
- value
- 6
- units
- Participants
- title
- Tmax Hx-DR5-05 Cycle 1 Day 1
- categories
- measurements
- group Id
- OG000
- lower Limit
- 1.1
- upper Limit
- 5.1
- value
- 3.12
- group Id
- OG001
- lower Limit
- 1.0
- upper Limit
- 3.5
- value
- 2.19
- group Id
- OG002
- lower Limit
- 1.0
- upper Limit
- 1.4
- value
- 1.19
- group Id
- OG003
- lower Limit
- 1.2
- upper Limit
- 5.1
- value
- 2.26
- group Id
- OG004
- lower Limit
- 1.1
- upper Limit
- 3.3
- value
- 2.31
- group Id
- OG005
- lower Limit
- 1.2
- upper Limit
- 3.2
- value
- 2.21
- denoms
- counts
- group Id
- OG000
- value
- 9
- group Id
- OG001
- value
- 4
- group Id
- OG002
- value
- 4
- group Id
- OG003
- value
- 8
- group Id
- OG004
- value
- 4
- group Id
- OG005
- value
- 2
- units
- Participants
- title
- Tmax Hx-DR5-05 Cycle 2 Day 1
- categories
- measurements
- group Id
- OG000
- lower Limit
- 0.0
- upper Limit
- 1.5
- value
- 1.08
- group Id
- OG001
- lower Limit
- 1.0
- upper Limit
- 3.3
- value
- 1.83
- group Id
- OG002
- lower Limit
- 1.1
- upper Limit
- 1.3
- value
- 1.18
- group Id
- OG003
- lower Limit
- 1.1
- upper Limit
- 3.0
- value
- 1.42
- group Id
- OG004
- lower Limit
- 1.0
- upper Limit
- 1.8
- value
- 1.13
- group Id
- OG005
- lower Limit
- 3.1
- upper Limit
- 3.1
- value
- 3.1
- denoms
- counts
- group Id
- OG000
- value
- 7
- group Id
- OG001
- value
- 4
- group Id
- OG002
- value
- 2
- group Id
- OG003
- value
- 6
- group Id
- OG004
- value
- 3
- group Id
- OG005
- value
- 1
- units
- Participants
- title
- Tmax Hx-DR5-05 Cycle 3 Day 1
- denoms
- counts
- group Id
- OG000
- value
- 9
- group Id
- OG001
- value
- 7
- group Id
- OG002
- value
- 4
- group Id
- OG003
- value
- 11
- group Id
- OG004
- value
- 7
- group Id
- OG005
- value
- 6
- units
- Participants
- description
- The Tmax of Hx-DR5-01 and Hx-DR5-05 are reported.
- dispersion Type
- Full Range
- groups
- description
- Participants received 0.1 mg/kg of GEN1029 every 2 weeks (Q2W) until the end of treatment.
- id
- OG000
- title
- 1. Biweekly Regimen (GEN1029 0.1 mg/kg)
- description
- Participants received 0.2 mg/kg of GEN1029 Q2W until the end of treatment.
- id
- OG001
- title
- 2. Biweekly Regimen (GEN1029 0.2 mg/kg)
- description
- Participants received 0.3 mg/kg of GEN1029 Q2W until the end of treatment.
- id
- OG002
- title
- 3. Biweekly Regimen (GEN1029 0.3 mg/kg)
- description
- Participants received 1.0 mg/kg of GEN1029 Q2W until the end of treatment.
- id
- OG003
- title
- 4. Biweekly Regimen (GEN1029 1.0 mg/kg)
- description
- Participants received 2.0 mg/kg of GEN1029 Q2W until the end of treatment.
- id
- OG004
- title
- 5. Biweekly Regimen (GEN1029 2.0 mg/kg)
- description
- Participants received 3.0 mg/kg of GEN1029 Q2W until the end of treatment.
- id
- OG005
- title
- 6. Biweekly Regimen (GEN1029 3.0 mg/kg)
- param Type
- MEDIAN
- population Description
- PK analysis set included all participants who were exposed to at least 1 dose of GEN1029 and who had at least 1 post-dose PK measurement. 'Number analyzed' denotes the number of participants evaluated for the specified time point.
- reporting Status
- POSTED
- time Frame
- Predose, end of infusion, 2, 4, 24, 48, 168 and 336 hours after end of infusion on Day 1 of Cycles 1, 2, 3
- title
- Time to Reach Maximum Observed Concentration (Tmax) of Hx-DR5-01 and Hx-DR5-05
- type
- SECONDARY
- unit Of Measure
- h
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice